Isotracin

Isotretinoin, the active ingredient in Isotracin, is a retinoid presented as an oral dosage form for oral use. It is indicated for the treatment of severe nodular acne and acne vulgaris in patients who have not responded adequately to conventional therapies. It works by reducing sebaceous gland size and sebum production, normalizing follicular keratinization, and exerting anti‑inflammatory effects.

GNH USA supplies Isotracin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution.

Isotracin (isotretinoin) is a retinoid used in the management of acne disorders. - Severe nodular acne: reduces inflammatory lesions and prevents formation of new nodules, leading to long‑term skin clearance. - Acne vulgaris: improves overall lesion count and severity in moderate to severe cases resistant to topical therapy. - Cystic acne: diminishes deep‑lying cysts and promotes faster healing of existing lesions.

Isotracin may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dry skin and mucous membranes. - Cheilitis (cracked lips). - Photosensitivity (increased sun sensitivity). - Elevated liver enzymes. - Hypertriglyceridemia.

Serious or Rare Side Effects: - Severe depression, suicidal ideation, or psychosis. - Teratogenic effects causing birth defects. - Inflammatory bowel disease flare. - Pancreatitis. - Severe hypervitaminosis A symptoms.

When prescribing Isotracin, clinicians should observe several safety measures. - Pregnancy: contraindicated; isotretinoin is teratogenic (Category X). - Birth control: effective contraception required for females of child‑bearing potential during treatment and for one month after. - Liver function: monitor hepatic enzymes before and during therapy. - Lipid profile: assess triglycerides and cholesterol periodically. - Store at ambient temperature: keep below 25 °C, retain in original container, protect from moisture and light.

Isotracin can interact with several medicines; awareness of interaction severity guides management.

Major Interactions (Avoid): - Tetracycline antibiotics: increased risk of intracranial hypertension. - Vitamin A supplements: additive toxicity leading to hypervitaminosis A. - Systemic retinoids: cumulative teratogenic risk.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may reduce efficacy; monitor menstrual cycles. - Anticoagulants: isotretinoin may enhance anticoagulant effect; check INR. - Corticosteroids: may mask signs of infection; observe clinical response.